Literature DB >> 21272004

Acetate supplementation attenuates lipopolysaccharide-induced neuroinflammation.

Chris J Reisenauer1, Dhaval P Bhatt, Dane J Mitteness, Evan R Slanczka, Heidi M Gienger, John A Watt, Thad A Rosenberger.   

Abstract

Glyceryl triacetate (GTA), a compound effective at increasing circulating and tissue levels of acetate was used to treat rats subjected to a continual 28 day intra-ventricular infusion of bacterial lipopolysaccharide (LPS). This model produces a neuroinflammatory injury characterized by global neuroglial activation and a decrease in choline acetyltransferase immunoreactivity in the basal forebrain. During the LPS infusion, rats were given a daily treatment of either water or GTA at a dose of 6 g/kg by oral gavage. In parallel experiments, free-CoA and acetyl-CoA levels were measured in microwave fixed brains and flash frozen heart, liver, kidney and muscle following a single oral dose of GTA. We found that a single oral dose of GTA significantly increased plasma acetate levels by 15 min and remained elevated for up to 4 h. At 30 min the acetyl-CoA levels in microwave-fixed brain and flash frozen heart and liver were increased at least 2.2-fold. The concentrations of brain acetyl-CoA was significantly increased between 30 and 45 min following treatment and remained elevated for up to 4 h. The concentration of free-CoA in brain was significantly decreased compared to controls at 240 min. Immunohistochemical and morphological analysis demonstrated that a daily treatment with GTA significantly reduced the percentage of reactive glial fibrillary acidic protein-positive astrocytes and activated CD11b-positive microglia by 40-50% in rats subjected to LPS-induced neuroinflammation. Further, in rats subjected to neuroinflammation, GTA significantly increased the number of choline acetyltransferase (ChAT)-positive cells by 40% in the basal forebrain compared to untreated controls. These data suggest that acetate supplementation increases intermediary short chain acetyl-CoA metabolism and that treatment is potentially anti-inflammatory and neuroprotective with regards to attenuating neuroglial activation and increasing ChAT immunoreactivity in this model.
© 2011 The Authors. Journal of Neurochemistry © 2011 International Society for Neurochemistry.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21272004      PMCID: PMC3070819          DOI: 10.1111/j.1471-4159.2011.07198.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  64 in total

Review 1.  Mitochondrial bioenergetics, aging, and aging-related disease.

Authors:  David Nicholls
Journal:  Sci Aging Knowledge Environ       Date:  2002-08-07

2.  Astrocytes in injury states rapidly produce anti-inflammatory factors and attenuate microglial inflammatory responses.

Authors:  Jong-Hyeon Kim; Kyoung-Jin Min; Wongi Seol; Ilo Jou; Eun-Hye Joe
Journal:  J Neurochem       Date:  2010-10-12       Impact factor: 5.372

3.  Rat brain docosahexaenoic acid metabolism is not altered by a 6-day intracerebral ventricular infusion of bacterial lipopolysaccharide.

Authors:  Thad A Rosenberger; Nelly E Villacreses; Margaret T Weis; Stanley I Rapoport
Journal:  Neurochem Int       Date:  2009-12-22       Impact factor: 3.921

Review 4.  Reactive astrocytes: cellular and molecular cues to biological function.

Authors:  J L Ridet; S K Malhotra; A Privat; F H Gage
Journal:  Trends Neurosci       Date:  1997-12       Impact factor: 13.837

5.  Adenosine A2A receptor activation reduces proinflammatory events and decreases cell death following intracerebral hemorrhage.

Authors:  M Mayne; J Fotheringham; H J Yan; C Power; M R Del Bigio; J Peeling; J D Geiger
Journal:  Ann Neurol       Date:  2001-06       Impact factor: 10.422

6.  Decrease and structural modifications of phosphatidylethanolamine plasmalogen in the brain with Alzheimer disease.

Authors:  Z Guan; Y Wang; N J Cairns; P L Lantos; G Dallner; P J Sindelar
Journal:  J Neuropathol Exp Neurol       Date:  1999-07       Impact factor: 3.685

7.  The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.

Authors:  F M Sacks; M A Pfeffer; L A Moye; J L Rouleau; J D Rutherford; T G Cole; L Brown; J W Warnica; J M Arnold; C C Wun; B R Davis; E Braunwald
Journal:  N Engl J Med       Date:  1996-10-03       Impact factor: 91.245

8.  Glutamate receptor-induced 45Ca2+ accumulation in cortical cell culture correlates with subsequent neuronal degeneration.

Authors:  D M Hartley; M C Kurth; L Bjerkness; J H Weiss; D W Choi
Journal:  J Neurosci       Date:  1993-05       Impact factor: 6.167

9.  Immunocytochemical study of an early microglial activation in ischemia.

Authors:  J Gehrmann; P Bonnekoh; T Miyazawa; K A Hossmann; G W Kreutzberg
Journal:  J Cereb Blood Flow Metab       Date:  1992-03       Impact factor: 6.200

Review 10.  Pathways of neurodegeneration and experimental models of basal ganglia disorders: downstream effects of mitochondrial inhibition.

Authors:  Massimiliano Di Filippo; Barbara Picconi; Cinzia Costa; Vincenza Bagetta; Michela Tantucci; Lucilla Parnetti; Paolo Calabresi
Journal:  Eur J Pharmacol       Date:  2006-06-16       Impact factor: 4.432

View more
  28 in total

1.  Acetate treatment increases fatty acid content in LPS-stimulated BV2 microglia.

Authors:  Dhaval P Bhatt; Thad A Rosenberger
Journal:  Lipids       Date:  2014-05-23       Impact factor: 1.880

2.  Modulation of inflammatory cytokines and mitogen-activated protein kinases by acetate in primary astrocytes.

Authors:  Mahmoud L Soliman; Colin K Combs; Thad A Rosenberger
Journal:  J Neuroimmune Pharmacol       Date:  2012-12-12       Impact factor: 4.147

3.  Microbiota composition modulates inflammation and neointimal hyperplasia after arterial angioplasty.

Authors:  Cori A Cason; Thomas M Kuntz; Edmund B Chen; Kelly Wun; Michael J Nooromid; Liqun Xiong; Neil R Gottel; Katharine G Harris; Timothy C Morton; Michael J Avram; Eugene B Chang; Jack A Gilbert; Karen J Ho
Journal:  J Vasc Surg       Date:  2020-02-05       Impact factor: 4.268

4.  Acetate supplementation increases brain histone acetylation and inhibits histone deacetylase activity and expression.

Authors:  Mahmoud L Soliman; Thad A Rosenberger
Journal:  Mol Cell Biochem       Date:  2011-02-26       Impact factor: 3.396

Review 5.  A translational perspective on histone acetylation modulators in psychiatric disorders.

Authors:  Surajit Ganguly; Subhendu Seth
Journal:  Psychopharmacology (Berl)       Date:  2018-06-19       Impact factor: 4.530

6.  Acetate supplementation increases brain phosphocreatine and reduces AMP levels with no effect on mitochondrial biogenesis.

Authors:  Dhaval P Bhatt; Heidi M Houdek; John A Watt; Thad A Rosenberger
Journal:  Neurochem Int       Date:  2013-01-12       Impact factor: 3.921

7.  Acetate reduces PGE2 release and modulates phospholipase and cyclooxygenase levels in neuroglia stimulated with lipopolysaccharide.

Authors:  Mahmoud L Soliman; Joyce E Ohm; Thad A Rosenberger
Journal:  Lipids       Date:  2013-05-25       Impact factor: 1.880

8.  Lipopolysaccharide-induced blood brain barrier permeability is enhanced by alpha-synuclein expression.

Authors:  Adam Jangula; Eric J Murphy
Journal:  Neurosci Lett       Date:  2013-07-19       Impact factor: 3.046

9.  Acetate reduces microglia inflammatory signaling in vitro.

Authors:  Mahmoud L Soliman; Kendra L Puig; Colin K Combs; Thad A Rosenberger
Journal:  J Neurochem       Date:  2012-09-28       Impact factor: 5.372

10.  Acetate Attenuates Lipopolysaccharide-Induced Nitric Oxide Production Through an Anti-Oxidative Mechanism in Cultured Primary Rat Astrocytes.

Authors:  Mitsuaki Moriyama; Ryosuke Kurebayashi; Kenji Kawabe; Katsura Takano; Yoichi Nakamura
Journal:  Neurochem Res       Date:  2016-08-20       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.